Peter Kölblinger

Research output

Research output per year 2013 2019 2020 2023 2024 2025

• 26 Original Article
• 8 Letter to the editor
• 6 Review article
• 3 Case report
• 5 More
  • 3 Editorial
  • 1 Abstract
  • 1 Abstract (Journal)

Research output per year

Research output per year

Search results

• 2025

  Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy

  Schumann, K., Klespe, K. C., Mauch, C., Loquai, C., Schultheis, U., Boerger, S., Thiem, A., Emmert, S., Hoellwerth, M. (Co-author), Koelbinger, P. (Co-author), Nguyen, V. A., Wanner, M., Richtig, E., Peitsch, W. K., Harth, W., Zenderowski, V., Braun, A. D., Mengoni, M., Dummer, R. & Mangana, J. & 6 others, Maul, L. V., Meis, F., Rappersberger, K., Persa, O. D., Biedermann, T. & Posch, C., 7 May 2025, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 10 p.

  Research output: Contribution to journal › Original Article › peer-review

  Open Access

  • Melanoma 100%
  • Recurrence Free Survival 100%
  • Adjuvant Therapy 100%
  • Pembrolizumab 75%
  • Trametinib 75%
• 2024

  Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial

  Richtig, E., Nguyen, V. A., Koelblinger, P. (Co-author), Wolf, I., Kehrer, H., Saxinger, W., Ressler, J. M., Weinlich, G., Meyersburg, D. (Co-author), Hafner, C., Jecel-Grill, E., Kofler, J., Lange-Asschenfeldt, B., Weihsengruber, F., Rappersberger, K., Svastics, N., Gasser, K., Seeber, A., Kratochvill, F. & Nagler, S. & 2 others, Mraz, B. & Hoeller, C., Apr 2024, In: MELANOMA RESEARCH . 34, 2, p. 142-151 10 p.

  Research output: Contribution to journal › Original Article › peer-review

  Open Access

  • Progression Free Survival 100%
  • Dabrafenib 100%
  • Trametinib 100%
  • Melanoma 100%
  • Overall Survival 80%
  2 Citations (Web of Science)

• Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis

  Brandlmaier, M. (First author), Hoellwerth, M. (Co-author), Silly, T., Hoeller, C., Koch, L., Richtig, E., Binder, K., Lange-Asschenfeldt, B., Barta, M., Schmid-Simbeck, M., Froehlich, F., Dummer, R., Muigg, L., Hitzl, W. (Co-author) & Koelblinger, P. (Last author), 20 Nov 2024, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 10 p.

  Research output: Contribution to journal › Original Article › peer-review

  Open Access

  • Pancreas Enzyme 100%
  • Pancreatic Lipase 45%
  • Pancreas Injury 45%
  • Triacylglycerol Lipase 45%
  • Pancreatitis 27%

• Prognostic Value of Baseline ¹⁸F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients

  Kalantari, F., Mirshahvalad, S., Hoellwerth, M. (Co-author), Schweighofer-Zwink, G. (Co-author), Huber-Schönauer, U., Hitzl, W. (Co-author), Rendl, G. (Co-author), Koelblinger, P. (Co-author), Pirich, C. & Beheshti, M. (Last author), Jan 2024, In: Cancers. 16, 1, 12 p., 127.

  Research output: Contribution to journal › Original Article › peer-review

  Open Access

  • Fluorodeoxyglucose F 18 100%
  • Brain Metastasis 100%
  • Positron Emission Tomography-Computed Tomography 100%
  • Melanoma 100%
  • Polyethylene Terephthalate 100%
• 2023

  Impact of [F-18]FDG PET/CT in the Assessment of Immunotherapy-Induced ArterialWall Inflammation in Melanoma Patients Receiving Immune Checkpoint Inhibitors

  Ranjbar, S., Zakavi, S., Eisazadeh, R., Mirshahvalad, S., Pilz, J. (Co-author), Jamshidi-Araghi, Z., Schweighofer-Zwink, G. (Co-author), Koelblinger, P. (Co-author), Pirich, C. (Co-author) & Beheshti, M. (Last author), 2023, In: DIAGNOSTICS. 13, 9, p. 1617

  Research output: Contribution to journal › Original Article › peer-review
  3 Citations (Web of Science)

• Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study)-Phase II data covering impact of concomitant haematological malignancies.

  Lang, R. (First author), Welponer, T. (Co-author), Richtig, E., Wolf, I., Hoeller, C., Hafner, C., Nguyen, V. A., Kofler, J., Barta, M., Koelblinger, P. (Co-author), Hitzl, W. (Co-author), Emberger, M. & Laimer, M. (Last author), 2023, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 37, 9, p. 1799-1810

  Research output: Contribution to journal › Original Article › peer-review
  10 Citations (Web of Science)

• Predictive value and accuracy of [F-18]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma

  Ayati, N., Jamshidi-Araghi, Z., Hoellwerth, M. (Co-author), Schweighofer-Zwink, G. (Co-author), Hitzl, W. (Co-author), Koelblinger, P. (Co-author), Pirich, C. (Co-author) & Beheshti, M. (Last author), Jul 2023, In: EUR J NUCL MED MOL IMAGING. 50, 9, p. 2715-2726 12 p.

  Research output: Contribution to journal › Original Article › peer-review
  2 Citations (Web of Science)

• Predictive value of baseline quantitative parameters of 2-[¹⁸F]FDG-PET/CT for brain metastases in melanoma patients

  Kalantari, F., Mirshahvalad, S., Hoellenwerth, M., Schweighofer-Zwink, G. (Co-author), Huber-Schönauer, U., Hitzl, W. (Co-author), Rendl, G. (Co-author), Koelblinger, P. (Co-author), Pirich, C. (Co-author) & Beheshti, M. (Last author), 2023, In: EUR J NUCL MED MOL IMAGING. 50, SUPPL 1, p. S193-S193

  Research output: Contribution to journal › Original Article › peer-review

  Open Access

• Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

  Schumann, K., Mauch, C., Klespe, K., Loquai, C., Nikfarjam, U., Schlaak, M., Akcetin, L., Kolblinger, P. (Co-author), Hoellwerth, M. (Co-author), Meissner, M., Mengi, G., Braun, A., Mengoni, M., Dummer, R., Mangana, J., Sindrilaru, M., Radmann, D., Hafner, C., Freund, J. & Rappersberger, K. & 48 others, Weihsengruber, F., Meiss, F., Reinhardt, L., Meier, F., Rainer, B., Richtig, E., Ressler, J., Holler, C., Eigentler, T., Amaral, T., Peitsch, W., Hillen, U., Harth, W., Ziller, F., Schatton, K., Gambichler, T., Susok, L., Maul, L., Laubli, H., Debus, D. (Co-author), Weishaupt, C., Borger, S., Sievers, K., Haferkamp, S., Zenderowski, V., Nguyen, V., Wanner, M., Gutzmer, R., Terheyden, P., Kahler, K., Emmert, S., Thiem, A., Sachse, M., Gercken-Riedel, S., Kaune, K., Thoms, K., Heinzerling, L., Heppt, M., Tratzmiller, S., Hoetzenecker, W., Ollinger, A., Steiner, A., Peinhaupt, T., Podda, M., Schmid, S., Wollina, U., Biedermann, T. & Posch, C., May 2023, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 37, 5, p. 894-906 13 p.

  Research output: Contribution to journal › Original Article › peer-review
  22 Citations (Web of Science)

• The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.

  Troesch, A., Hoellwerth, M. (Co-author), Forchhammer, S., Del Regno, L., Lodde, G., Turko, P., Cheng, P. F., Levesque, M. L., Hadaschik, E., Livingstone, E., Peris, K., Flatz, L., Koelblinger, P. (Co-author), Dummer, R. & Dimitriou, F., May 2023, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 37, 5, p. 922-931 10 p.

  Research output: Contribution to journal › Original Article › peer-review
  14 Citations (Web of Science)
• 2022

  Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis

  Goldinger, S., Buder-Bakhaya, K., Lo, S., Forschner, A., McKean, M., Zimmer, L., Khoo, C., Dummer, R., Eroglu, Z., Buchbinder, E., Ascierto, P., Gutzmer, R., Rozeman, E., Hoeller, C., Johnson, D., Gesierich, A., Koelblinger, P. (Co-author), Bennannoune, N., Cohen, J. & Kahler, K. & 20 others, Wilson, M., Cebon, J., Atkinson, V., Smith, J., Michielin, O., Long, G., Hassel, J., Weide, B., Haydu, L., Schadendorf, D., McArthur, G., Ott, P., Blank, C., Robert, C., Sullivan, R., Hauschild, A., Carlino, M., Garbe, C., Davies, M. & Menzies, A., 2022, In: EUROPEAN JOURNAL OF CANCER . 162, p. 22-33

  Research output: Contribution to journal › Original Article › peer-review
  36 Citations (Web of Science)

• Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity.

  Weber, D. (First author), Aminzadeh-Gohari, S. (First author), Thapa, M., Redtenbacher, A.-S., Catalano, L. (Co-author), Capelôa, T., Vazeille, T., Emberger, M., Felder, T. (Co-author), Feichtinger, R. (Co-author), Koelblinger, P. (Co-author), Dallmann, G., Sonveaux, P., Lang, R. (Co-author) & Kofler, B. (Last author), 2022, In: CANCER & METABOLISM. 10, 1, p. 12

  Research output: Contribution to journal › Original Article › peer-review
  16 Citations (Web of Science)

• Prognostic value of 2-[ 18 F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy

  Schweighofer-Zwink, G. (First author), Manafi-Farid, R., Kölblinger, P. (Co-author), Hehenwarter, L. (Co-author), Harsini, S., Pirich, C. (Co-author) & Beheshti, M. (Last author), 2022, In: EUROPEAN JOURNAL OF RADIOLOGY . 146, p. 110107

  Research output: Contribution to journal › Original Article › peer-review
  14 Citations (Web of Science)
• 2021

  Adjuvant anti-PD-1 antibody treatment in stage III/IV melanoma: real-world experience and health economic considerations.

  Koelblinger, P. (First author), Hoellwerth, M. (Co-author), Dernoscheg, M.-T., Koch, L., Richtig, E., Wanner, M., Nguyen, V.-A., Ostermann, H., Bauer, J. (Co-author) & Laimer, M. (Last author), 2021, In: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 19, 8, p. 1186-1198

  Research output: Contribution to journal › Original Article › peer-review
  14 Citations (Web of Science)

• Adjuvante Anti-PD-1-Antikörpertherapie bei Stadium-III/IV-Melanom: Anwendungsdaten aus der klinischen Routine und gesundheitsökonomische Aspekte

  Kölblinger, P. (First author), Höllwerth, M. (Co-author), Dernoscheg, M.-T., Koch, L., Richtig, E., Wanner, M., Nguyen, V.-A., Ostermann, H., Bauer, J. (Co-author) & Laimer, M. (Last author), 2021, In: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 19, 8, p. 1186-1200

  Research output: Contribution to journal › Original Article › peer-review

• COVID-19-Induced Reduction in Primary Melanoma Diagnoses: Experience from a Dermatopathology Referral Center.

  Hoellwerth, M. (First author), Kaiser, A. (Co-author), Emberger, M., Brandlmaier, M. (Co-author), Laimer, M. (Co-author), Egger, A., Bauer, J. (Co-author) & Koelblinger, P. (Last author), 2021, In: Journal of Clinical Medicine. 10, 18

  Research output: Contribution to journal › Original Article › peer-review
  17 Citations (Web of Science)

• Targeted Metabolomics Identifies Plasma Biomarkers in Mice with Metabolically Heterogeneous Melanoma Xenografts.

  Weber, D. (First author), Thapa, M., Aminzadeh-Gohari, S. (Co-author), Redtenbacher, A.-S., Catalano, L. (Co-author), Feichtinger, R. (Co-author), Koelblinger, P. (Co-author), Dallmann, G., Emberger, M., Kofler, B. (Co-author) & Lang, R. (Last author), 2021, In: Cancers. 13, 3

  Research output: Contribution to journal › Original Article › peer-review
  12 Citations (Web of Science)
• 2020

  Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.

  Cerezo-Wallis, D., Contreras-Alcalde, M., Troulé, K., Catena, X., Mucientes, C., Calvo, T. G., Cañón, E., Tejedo, C., Pennacchi, P. C., Hogan, S., Kölblinger, P. (Co-author), Tejero, H., Chen, A. X., Ibarz, N., Graña-Castro, O., Martinez, L., Muñoz, J., Ortiz-Romero, P., Rodriguez-Peralto, J. L. & Gómez-López, G. & 5 others, Al-Shahrour, F., Rabadán, R., Levesque, M. P., Olmeda, D. & Soengas, M. S., 2020, In: NATURE MEDICINE. 26, 12, p. 1865-1877

  Research output: Contribution to journal › Original Article › peer-review
  79 Citations (Web of Science)

• Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.

  Ludwig, S. V., F Cheng, P., Mangana, J., Braun, R., Dummer, R. & Koelblinger, P. (Last author), 2020, In: EUROPEAN JOURNAL OF DERMATOLOGY . 30, 6, p. 6-709

  Research output: Contribution to journal › Original Article › peer-review
  1 Citation (Web of Science)

• The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma.

  Kaufmann, C., Kempf, W., Mangana, J., Cheng, P., Emberger, M., Lang, R. (Co-author), Kaiser, A. (Co-author), Lattmann, E., Levesque, M., Dummer, R. & Koelblinger, P. (Last author), 2020, In: HISTOPATHOLOGY . 77, 3, p. 460-470

  Research output: Contribution to journal › Original Article › peer-review
  16 Citations (Web of Science)
• 2019

  Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.

  Pires da Silva, I., Glitza, I. C., Haydu, L. E., Johnpulle, R., Banks, P. D., Grass, G. D., Goldinger, S. M. A., Smith, J. L., Everett, A. S., Koelblinger, P. (Co-author), Roberts-Thomson, R., Millward, M., Atkinson, V. G., Guminski, A., Kapoor, R., Conry, R. M., Carlino, M. S., Wang, W., Shackleton, M. J. & Eroglu, Z. & 5 others, Lo, S., Hong, A. M., Long, G. V., Johnson, D. B. & Menzies, A. M., 2019, In: PIGMENT CELL & MELANOMA RESEARCH. 32, 4, p. 553-563

  Research output: Contribution to journal › Original Article › peer-review
  27 Citations (Web of Science)

• Increased tumour cell PD-L1 expression, macrophage and dendritic cell infiltration characterise the tumour microenvironment of ulcerated primary melanomas.

  Koelblinger, P. (First author), Emberger, M., Drach, M., Cheng, P. F., Lang, R. (Co-author), Levesque, M. P., Bauer, J. (Co-author) & Dummer, R., 2019, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 33, 4, p. 667-675

  Research output: Contribution to journal › Original Article › peer-review
  21 Citations (Web of Science)

• The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanoma.

  Graf, N. P., Koelblinger, P. (Co-author), Galliker, N., Conrad, S., Barysch, M., Mangana, J., Dummer, R., Cheng, P. F. & Goldinger, S. M., 2019, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 33, 4, p. 686-692

  Research output: Contribution to journal › Original Article › peer-review
  16 Citations (Web of Science)
• 2018

  Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.

  Clocchiatti, A., Ghosh, S., Procopio, M.-G., Mazzeo, L., Bordignon, P., Ostano, P., Goruppi, S., Bottoni, G., Katarkar, A., Levesque, M., Kölblinger, P. (Co-author), Dummer, R., Neel, V., Özdemir, B. C. & Dotto, G. P., 2018, In: JOURNAL OF CLINICAL INVESTIGATION. 128, 12, p. 5531-5548

  Research output: Contribution to journal › Original Article › peer-review
  46 Citations (Web of Science)

• Development of encorafenib for BRAF-mutated advanced melanoma.

  Koelblinger, P. (First author), Thuerigen, O. & Dummer, R., 2018, In: CURRENT OPINION IN ONCOLOGY. 30, 2, p. 125-133

  Research output: Contribution to journal › Original Article › peer-review
  123 Citations (Web of Science)
• 2013

  Skin manifestations of outpatient adverse drug events in the United States: a national analysis.

  Koelblinger, P. (First author), Dabade, T. S., Gustafson, C. J., Davis, S. A., Yentzer, B. A., Kiracofe, E. A. & Feldman, S. R., 2013, In: JOURNAL OF CUTANEOUS MEDICINE AND SURGERY. 17, 4, p. 269-275

  Research output: Contribution to journal › Original Article › peer-review
  6 Citations (Web of Science)